Gland Pharma Limited — Others, 01-08-2025: News Verification

Gland Pharma has addressed stock exchange queries regarding a news report about global drug majors receiving letters seeking lower prices. The company clarified it is not a recipient of such communications and possesses no undisclosed material information that would explain any related stock movement. It stated that any decrease in its share price is likely due to general market conditions and the broader decline in healthcare and pharma indices. This update assures investors that the company is not directly impacted by the specific event mentioned in the news article, distinguishing its position from broader sector trends.